Biosynex SA (EPA:ALBIO)
0.9500
-0.0900 (-8.65%)
At close: Jan 28, 2026
Biosynex Employees
Biosynex had 476 employees as of December 31, 2024. The number of employees decreased by 93 or -16.34% compared to the previous year.
Employees
476
Change (1Y)
-93
Growth (1Y)
-16.34%
Revenue / Employee
€215,756
Profits / Employee
€156,363
Market Cap
19.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 476 | -93 | -16.34% |
| Dec 31, 2023 | 569 | 202 | 55.04% |
| Dec 31, 2022 | 367 | 107 | 41.15% |
| Dec 31, 2021 | 260 | 68 | 35.42% |
| Dec 31, 2020 | 192 | 48 | 33.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novacyt | 234 |
| Median Technologies | 225 |
| Carmat | 153 |
| Diagnostic Medical Systems | 140 |
| Bluelinea Société Anonyme | 89 |
| Affluent Medical | 78 |
| Mauna Kea Technologies | 61 |
| Implanet | 46 |